<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<REGINFO_RIN_DATA xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" RUN_DATE="2013-05-23-04:00" xsi:noNamespaceSchemaLocation="http://reginfo.gov/public/xml/REGINFO_XML_Ver10262011.xsd">
    <RIN_INFO>
        <RIN>0920-AA37</RIN>
        <PUBLICATION>
            <PUBLICATION_ID>201110</PUBLICATION_ID>
            <PUBLICATION_TITLE>The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions</PUBLICATION_TITLE>
        </PUBLICATION>
        <AGENCY>
            <CODE>0920</CODE>
            <NAME>Centers for Disease Control and Prevention</NAME>
            <ACRONYM>CDC</ACRONYM>
        </AGENCY>
        <PARENT_AGENCY>
            <CODE>0900</CODE>
            <NAME>Department of Health and Human Services</NAME>
            <ACRONYM>HHS</ACRONYM>
        </PARENT_AGENCY>
        <RULE_TITLE>Control of Communicable Diseases: Foreign and Possessions; Proposed Revision of CDC Etiological Agents Importation Regulations</RULE_TITLE>
        <ABSTRACT>By statute, CDC implements regulations found at 42 CFR 71.54 restricting the importation and transportation of etiologic agents.  Importers are required to complete an application for permit.  Under its current regulatory framework, policies and procedures, the EAIPP does not perform on-site inspections at these facilities prior to the issuance of an import permit.  Permits are issued based on a review of safety information provided by a potential importer in support of an import permit application.  Rule-making is needed with the aim of improving CDC's ability to prevent importation of communicable diseases into the United States.  CDC is considering whether to adopt a program similar to the U.S. Department of Agriculture/Animal and Plant Health Inspection Service Program such as conducting inspections on importer facilities prior to issuance of a permit for etiologic agents such as Mycobacterium tuberculosis and Hantavirus, providing an appeal process for denied applications.</ABSTRACT>
        <PRIORITY_CATEGORY>Other Significant</PRIORITY_CATEGORY>
        <RIN_STATUS>Previously Published in The Unified Agenda</RIN_STATUS>
        <RULE_STAGE>Proposed Rule Stage</RULE_STAGE>
        <MAJOR>No</MAJOR>
        <UNFUNDED_MANDATE_LIST>
            <UNFUNDED_MANDATE>No</UNFUNDED_MANDATE>
        </UNFUNDED_MANDATE_LIST>
        <CFR_LIST>
            <CFR>42 CFR 71.54</CFR>
        </CFR_LIST>
        <LEGAL_AUTHORITY_LIST>
            <LEGAL_AUTHORITY>PHA as amended (42 USC 216, 264 to 272)</LEGAL_AUTHORITY>
        </LEGAL_AUTHORITY_LIST>
        <LEGAL_DLINE_LIST/>
        <RPLAN_ENTRY>No</RPLAN_ENTRY>
        <TIMETABLE_LIST>
            <TIMETABLE>
                <TTBL_ACTION>NPRM</TTBL_ACTION>
                <TTBL_DATE>10/14/2011</TTBL_DATE>
                <FR_CITATION>76 FR 63891</FR_CITATION>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>NPRM Comment Period End</TTBL_ACTION>
                <TTBL_DATE>12/13/2011</TTBL_DATE>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>Final Action</TTBL_ACTION>
                <TTBL_DATE>09/00/2012</TTBL_DATE>
            </TIMETABLE>
        </TIMETABLE_LIST>
        <RFA_REQUIRED>No</RFA_REQUIRED>
        <SMALL_ENTITY_LIST>
            <SMALL_ENTITY>No</SMALL_ENTITY>
        </SMALL_ENTITY_LIST>
        <GOVT_LEVEL_LIST>
            <GOVT_LEVEL>None</GOVT_LEVEL>
        </GOVT_LEVEL_LIST>
        <ENERGY_AFFECTED>No</ENERGY_AFFECTED>
        <PRINT_PAPER>No</PRINT_PAPER>
        <INTERNATIONAL_INTEREST>No</INTERNATIONAL_INTEREST>
        <AGENCY_CONTACT_LIST>
            <CONTACT>
                <FIRST_NAME>Robbin</FIRST_NAME>
                <LAST_NAME>Weyant</LAST_NAME>
                <TITLE>Director, Division of Select Agents and Toxins</TITLE>
                <AGENCY>
                    <CODE>0920</CODE>
                    <NAME>Centers for Disease Control and Prevention</NAME>
                    <ACRONYM>CDC</ACRONYM>
                </AGENCY>
                <PHONE>404 718-2000</PHONE>
                <EMAIL>rweyant@cdc.gov</EMAIL>
                <MAILING_ADDRESS>
                    <STREET_ADDRESS>MS A-46, Clifton Road NE.,</STREET_ADDRESS>
                    <CITY>Atlanta</CITY>
                    <STATE>GA</STATE>
                    <ZIP>30333</ZIP>
                </MAILING_ADDRESS>
            </CONTACT>
        </AGENCY_CONTACT_LIST>
    </RIN_INFO>
</REGINFO_RIN_DATA>
